Tag: OPS SCS services

  • Organizations Worldwide Denounce Ontario’s Decision to Defund Remaining Supervised Consumption Sites

    Organizations Worldwide Denounce Ontario’s Decision to Defund Remaining Supervised Consumption Sites

    For Immediate Release

    Toronto, ON | March 31, 2026––Today, exactly one year since the Government of Ontario forced nine Consumption and Treatment Services sites (CTS, also known as supervised consumption sites, or SCS) to close across the province, more than 250 organizations — led by the HIV Legal Network, the Drug Strategy Network of Ontario, and the Canadian Drug Policy Coalition — have sent a clear message to the Government of Ontario. Together, they are calling on the government to respect the expert advice of organizations with unparalleled experience on substance use issues, follow the mounting evidence demonstrating the clear need for SCS, and pledge to keep individuals and neighborhoods safer for everyone by reversing the misguided decision to defund the remaining eight funded CTS sites in Ontario.

    Despite claims from the province that the closure of CTS sites last March caused no problem, data shared at a media conference today highlight a troubling trend: Ontario-wide data shows a sharp increase in EMS calls (+69.5%) and emergency department use (+67%) for opioid-related overdoses in the period following the forced closure of nine CTS sites in March 2025 under the so-called Community Care and Recovery Act.

    “These trends are troubling and warrant very careful scrutiny by the province,” says Dr. Gillian Kolla, Faculty of Medicine, Memorial University. “The timing and magnitude of these increases are consistent with concerns that were raised at the time of the closures to the Government of Ontario by countless public health experts, including their own internal advisors. The government has an obligation to take these trends seriously and to consider what role the removal of supervised consumption services may have played.”

    In the City of Toronto, EMS calls for opioid-related toxicities have increased by 82% since the closures of CTS sites, rising from 192 calls in March 2025 to 350 monthly calls in January 2026, a sharp upward shift consistent with what experts warned would happen following site closures, and starkly at odds with the prior downward trend. In Hamilton, where the city’s CTS closed in April 2025, opioid-related EMS responses rose from 66 in April 2025 to 199 in February 2026 — the highest recorded monthly count since reporting began. Taken together, these trends raise serious concerns about the flawed and ultimately inconclusive Alberta crown corporation study recently invoked by the Ontario government to justify the closures.

    The eight remaining sites to be defunded in June 2026 have served 120,997 unique people and reversed 15,402 overdose emergencies, aided by exceptional client-provider relationships and an impressive suite of wraparound services, including primary healthcare, voluntary addiction and mental health treatment opportunities, specialized social supports, and more.

    “As someone who has experienced both sides of the system, harm reduction is not theoretical to me — it is life-saving,” says Akosua Gyan-Mante. “I’ve gone from being a service user to now supporting others on the frontlines, and I’ve seen firsthand how compassion, dignity, and non-judgment can keep people alive long enough to access care and build stability.”

    Harm reduction initiatives and SCS are also proven to reduce Ontario’s tax burden by preventing HIV and hepatitis C transmission, among other cost-saving benefits.

    “The closure of these sites, and the wider and illogical attack on harm reduction in Ontario and across Canada, is deeply worrisome and already proving deadly,” says Sandra Ka Hon Chu, Co-Executive Director of the HIV Legal Network. “Starving supervised consumption sites of funding and pressuring people into an abstinence-only model — including HART Hubs — will not work. Supervised consumption is a key part of the response to the crisis of our toxic, unregulated drug supply: it cannot be replaced.”

    “We strongly encourage the advancement of drug policies that help, not harm, individual and community health and safety,” says Michael Parkinson, Executive Director of the Drug Strategy Network of Ontario. “The Government of Ontario has a duty to ensure the life, liberty, and security of all of its residents. Intentionally defunding proven interventions guarantees dangerous and expensive results, threatening the relief we all seek and deserve.”

    We are calling on the Government of Ontario to respect the evidence and immediately reverse its disastrous decision to further defund SCS and force their closure during an ongoing public health emergency of historic magnitude.

    -30-

    For the Evidence Brief that shares data on the impact of 2025 CTS closures in Ontario, please see What the Evidence Says about Defunding Ontario’s Remaining Supervised Consumption Sites.

    For more information on the need to scale up supervised consumption services Canada-wide, please see Scaling Up Supervised Consumption Services: What has changed in Canada?

    Media contact
    Dylan DeMarsh – [email protected]

  • FOR IMMEDIATE RELEASE: Silence from Ontario Ministry of Health as Time Runs Out to Save Supervised Consumption Sites 

    FOR IMMEDIATE RELEASE: Silence from Ontario Ministry of Health as Time Runs Out to Save Supervised Consumption Sites 

    Ontario, Canada | March 18, 2024 

    Two weeks have passed since 51 groups from across Ontario sent an open letter calling on the provincial government to immediately fund and support supervised consumption sites. But despite the coalition’s request for an emergency meeting by March 13, Minister of Health Sylvia Jones and Associate Minister of Mental Health and Addictions Michael Tibollo have not responded.

    The groups are speaking out to secure emergency funding and prevent impending closures of sites in Sudbury and Timmins. More than 500 people have died from drug poisoning in Ontario so far this year. 

    “I am horrified. This is a life-and-death emergency, and we are being ignored,” says Rev. George Bozanich of the Windsor CTS Advocacy Coalition. “Without these services, Ontarians die.  These are our children, parents, siblings and neighbours. I cannot imagine the Ministers and the Premier ignoring a similar lifesaving request on any other issue.”   

    Since the current provincial government came to power in 2018, unregulated drug deaths have surged. “Toxic drugs killed nine people every day in the first two months of this year,” says Beeta Senedjani of the Canadian Drug Policy Coalition. “The dead would fill every seat on at least eleven school buses. This is an emergency. The province needs to start acting like it.”   

    Supervised consumption sites are a proven health intervention where trained staff respond to overdose emergencies and offer supports and connections to health and social services. Evidence consistently shows the sites save lives and significantly reduce emergency calls and hospital visits.  

    “The province’s actions have put municipal governments, local health boards and even the public in the impossible position of having to either foot the bill for a provincial responsibility or watch their communities suffer,” says Matthew Shoemaker, Mayor of Sault Ste. Marie. “This crisis is a foremost challenge for municipalities, who don’t have the resources or the mandate to fund health care. We badly need stable support and action from the Government of Ontario and we need it now.”  

    “The entire years-long process has been an irresponsible use of public funds,” says Michael Brennan of Pozitive Pathways in Windsor, whose site was forced to close in December. “Supervised consumption sites are a proven lifesaving intervention that reduce costs and burdens across our public systems, on police, paramedics and emergency departments. We have complied with every requirement.  We cannot wait any longer.” 

    Last fall, the Province of Ontario put all supervised consumption site applications on indefinite hold pending a critical incident review for one site in Toronto. The decision came after a bystander was tragically killed in the vicinity of a Toronto site last summer.  

    “A lengthy review of a tragic, isolated incident is preventing desperate communities across the province from implementing lifesaving services amidst a public health emergency,” says Michael Parkinson of the Drug Strategy Network of Ontario. “Critical incidents occur frequently in other settings, such as hospitals. But they never result in freezing funding or site approvals.”  

    Several communities have waited for approval since long before the review. Barrie and Sudbury applied over two years ago. Citing the province’s pause, a Hamilton application was withdrawn after two years. In Sault Ste Marie, a site application is instead being directed to the federal government. Windsor’s only site shut its doors at the end of December after waiting over a year. Without immediate provincial funding, sites in Sudbury and Timmins will close in two weeks. 

    “When I think about losing Safe Health Site Timmins, I am afraid for our community,” says Jason Sereda of DIY Community Health in Timmins. “We are running out of time.” Premier Doug Ford has said the review results will be released this month, too late for those who have already died of drug poisoning. 

    The open letter calls for the elimination of unnecessary barriers and immediate sustained provincial funding for supervised consumption sites, including inhalation services, to meet the urgent needs of communities. The coalition emphasizes that these demands require immediate provincial action to prevent further loss of life and harm to communities across Ontario. 

    “Minister Jones, please listen to us. This is an emergency,” says Amber Fritz of Réseau ACCESS Network in Sudbury. “We need your leadership. You have a choice: you have the opportunity to save lives and costs to the system, or you can continue to do nothing. If our loved ones die, that will be your legacy.”   

    -30- 

    Documents and links available: 

    • Open Letter 
    • [Recording] March 5 2024 Online Briefing on Open Letter RE: Ontario Supervised Consumption Services with speakers from the Canadian Drug Policy Coalition, Pozitive Pathways in Windsor, Reseau ACCESS in Sudbury, Safe Health Site in Timmins and the Drug Strategy Network of Ontario.  

    Media Contact: 

    Jessica Hannon for the Canadian Drug Policy Coalition [contact to arrange interviews]

  • COVID-19: Responding to  Overdoses in OPS and SCS

    COVID-19: Responding to Overdoses in OPS and SCS

    responding to overdoses during covid responding to overdoses during covid

    “The context of BC’s dual public health emergencies related to the toxic drug supply and the COVID-19 pandemic requires providing access to harm reduction services including overdose prevention services (OPS) and supervised consumption services (SCS) while maintaining measures to prevent the spread of COVID-19. This document provides guidance on responding to illicit drug poisonings or overdoses in OPS/SCS settings, where there will be a need for flexibility and consideration of the facility, staff training and available resources when implementing public health guidelines for preventing the spread of COVID-19.”

    Click HERE for more COVID-19 resources

  • Reducing transmission of respiratory illness through improved indoor air quality

    Reducing transmission of respiratory illness through improved indoor air quality

    Improving ventilation for covid-19 Improving ventilation for covid-19

    “The following is an edited summary of a conversation with Dr. Jeffrey Siegel, Professor of Civil Engineering at the University of Toronto. Dr. Siegel is an expert on indoor air quality and ventilation. The conversation took place in late December, 2020. Some information was also added following the conversation by MAP.

    Respiratory illnesses like COVID-19 are spread in a few ways, including through the air. When people are together indoors, infections can spread more easily. But there are things you can do to improve indoor air quality and help reduce transmission. While this is particularly urgent during the COVID-19 pandemic, improvements to indoor air quality are important long-term investments at any time. For example, these improvements can help reduce transmission of long-standing respiratory illnesses such as flu and tuberculosis.

    Please note, the below focuses on airborne transmission, and does not address or replace other infection control measures such as masks, hand washing and the disinfection of surfaces.”

    Click HERE for more COVID-19 resources

  • Overdose prevention and response during COVID-19

    Overdose prevention and response during COVID-19

    Overdose prevention and response during COVID-19, Overdose prevention and response during COVID-19


    Click HERE for more resources

  • Syringe services program operational changes during COVID-19 outbreak

    Syringe services program operational changes during COVID-19 outbreak

    Syringe services program changes during COVID-19, Syringe services program changes during COVID-19,

    Click HERE for more resources

    “Syringe services program (SSP) operational changes during the COVID-19 global outbreak. Syringe services programs (SSPs) are community-based programs that offer tailored social and medical services to PWID, including access to sterile and clean injection equipment, onsite and referrals to sub- stance use treatment, HIV and Hepatitis C (HCV) testing, and overdose prevention through naloxone distribution. Currently, there are over 400 SSP locations across the United States (US) providing life-saving care to PWID. However, with the unprecedented developments regarding COVID-19, service delivery may be severely disrupted, and operational changes may be imperative to protect SSP staff and to ensure continuity of services. We provide preliminary data regarding SSP operational and service delivery changes during the US’ response to the COVID-19 global pandemic and provide key policy and service provision im- plications for SSPs.”

    Source: International Journal of Drug Policy

  • Supporting people who use drugs in acute care settings during COVID-19

    Supporting people who use drugs in acute care settings during COVID-19

    supporting people who use drugs in acute care, supporting people who use drugs in acute care


    Click HERE for more resources

    “This document is one of a series of six national guidance documents, rapidly developed by the CRISM network at the request of the Government of Canada. Collectively, the six documents address urgent needs of people who use drugs, service providers, and decision makers in relation to the COVID-19 pandemic. The urgent nature of this work required rapid development and dissemination of this guidance. This, and the continuing evolution of the knowledge base regarding COVID-19, precluded CRISM from conducting a comprehensive review of the relevant literature. However, when available, scientific evidence is cited in support of the expert advice offered herein.

    The guidance provided in this document is subject to change as new information becomes available. Readers should note that the intent of this document is to provide general guidance rather than detailed procedural and logistical advice. Readers are advised to consult local Public Health and medical authorities for specific input on navigating their own unique regulatory and policy environments, as necessary.”

    Source: CRISM

  • Harm Reduction and COVID-19 Guidance for Service Providers

    Harm Reduction and COVID-19 Guidance for Service Providers

    Alberta health services covid guidance, Alberta health services covid guidance


    Click HERE for more resources

    “This guidance document for community service providers was prepared by the Alberta Health Services (AHS) Harm Reduction Services Team in partnership with the Alberta Community Council on HIV (ACCH). It covers information on how community services may alter harm reduction practices during the COVID-19 pandemic with the goal of reducing the spread of COVID-19. This information can also be used by service providers to communicate information and education on reducing spread of COVID-19 while maintaining health and wellness along the spectrum of substance use.”

  • Strategies for a gender-inclusive response to COVID-19

    Strategies for a gender-inclusive response to COVID-19

    gender inclusive response to covid 19

    gender inclusive response to covid 19

    Click HERE for more resources

    “Public health strategies aimed at preventing the spread of COVID-19, including physical distancing, frequent hand washing, and self-isolation, impact all of us, and in particular, the marginalized communities that we work with. As we continue to work with community stakeholders to integrate these strategies, it is important to also integrate strategies that address the existing social determinants of health that impact WHAI’s priority populations of women (women living with HIV, African, Caribbean and Black [ACB] women including newcomers, Indigenous women, Trans women, women who use substances, women who experience violence, and women who are or have been incarcerated). Below are some considerations that have arisen to date.”

    Source: Women & HIV/AIDS Initiative